Eye Therapy News
Professor Ali honoured for his contribution to research into retinal disease
Mon, 08 Sep 2014 12:27:36 +0000
Professor Robin Ali, PhD, Professor of Human Molecular Genetics and Head of the Department of Genetics, UCL Institute of Opthalmology has been awarded the Pioneer Award for his work in proof-of-concept studies that have demonstrated the feasibility of using gene therapy and cell transplantation to treat dysfunction and degeneration of the cells […]Read more...
Achromatopsia might not be as progressive as previously thought
Mon, 08 Sep 2014 11:17:16 +0000
A recent publication from the UCL Institute of Ophthalmology, Moorfields Eye Hospital, and the Medical College of Wisconsin indicates that for the majority of people with achromatopsia, the condition may not be as progressive as previously suggested. Data from this study by Aboshiha et al. demonstrated that for the majority of people with achromatopsia (a […]Read more...
2 Lazy 2 Run? We’re biking it for blood cancer!
Fri, 29 Aug 2014 09:30:05 +0000
On Sunday 31 August a group of not so elite athletes from the Gene and Cell Therapy group will be taking part in the London Bikeathon 2014 to raise funds for Leukaemia & Lymphoma Research. The 2 Lazy 2 Run CC will be cycling 52 miles – that’s more than a marathon, no mean feet […]Read more...
The Art of Eyes
Thu, 07 Aug 2014 14:23:19 +0000
The eye is an object of great beauty as shown by the Ophthalmologist in their July/August 2014 issue. This month’s issue features a photo essay called The Art of the Eyes and includes examples of the work from a number research labs capturing the complex and beautiful detail of the eye and its cells. The essay includes images […]Read more...
Tue, 05 Aug 2014 16:02:34 +0000
Dr Yoshiki Sasai (1962 – 2014) It is with great sadness today that we remember and pay tribute to our collaborator Dr Yoshiki Sasai. Yoshiki was a world leading stem cell researcher and Deputy Director of the Riken Center for Developmental Biology in Kobe, Japan. Through his hard work and dedication over many years, Yoshiki […]Read more...
How to support our work - patient and public engagement
We are currently conducting two ground-breaking clinical trials:
- The world's first gene therapy trial in the eye, testing the safety and efficacy of delivering the RPE65 gene to patients with Leber congenital amaurosis (LCA).
- Europe's first trial testing the safety of transplanting stem cell-derived retinal cells into the eyes of patients with Stargardt disease.
We also have a wide-ranging research programme dedicated to developing novel gene and cell therapies for many forms of sight loss, including:
- inherited sight loss
- age-related macular degeneration (AMD)
- diabetic eye disease
- uveitis and
- corneal disease
We are grateful to the following funding bodies, charities and companies for their generous support:
The Gene Team appeal, by RP Fighting Blindness (formerly British Retinitis Pigmentosa Society (BRPS))
Fighting Blindness (USA)
TFC Frost Charitable Trust
Fighting Blindness Ireland
Medical Research Council (MRC)
The Wellcome Trust
RP Fighting Blindness (formerly British Retinitis Pigmentosa Society (BRPS))
Fight for Sight
The Royal Society
National Institute for Health Research
The Newman Foundation
Special Trustees of Moorfields
Moorfields Eye Charity
Biotechnology and Biological Sciences Research Council (BBSRC)
We have also received funding from these organisations in the past.
If you would like to contribute to our world class research programme, please choose one of the following options:
Page last modified on 11 sep 12 14:39